Scientists in Canada have developed a new drug that offers an unconventional approach to beat the flu virus.
The researchers who found the drug was effective in two different strains of mice and three different strains of flu believe the drug could be effective in animals other than mice, including humans.
Psychologists Say Memories of a Particular Dish Influence Food Choices
The neural and cognitive mechanism of our decision-making process about a food is greatly influenced by the memory we have about it.
Advertisement
Instead of targeting the virus that causes flu, the new drug can prevent the blood vessels from leaking fluid into the lung's air sacs.
People who die from the flu actually die from respiratory failure, when the lung's tiny blood vessels start leaking fluid into the lung's air sacs. The new drug, Vasculotide, developed by researchers at Sunnybrook Hospital in Toronto acts on the endothelial cells that line the blood vessels.
![Vaccines Developed For Chickens Against Two New Avian Influenza Strains]( "Vaccines Developed For Chickens Against Two New Avian Influenza Strains")
The vaccine contains a recombinant virus that fights against avian influenza virus subtype H5N1 that gets transmitted from poultry to humans.
The drug was effective against multiple strains of influenza, including the 2009 swine flu pandemic strain.
"While this research was conducted in mice, I found the results exciting since the drug was effective in two different strains of mice and three different strains of flu," said Warren Lee, a researcher with St. Michael's Hospital's Keenan Research Center for Biomedical Sciences, who tested the new drug on mice.
As the mechanism of blood vessels leaking into lungs is common throughout animals, Lee was optimistic that the drug could be effective in animals other than mice, including humans.
Without the drug, 100% of the mice died within one week. With the drug, more than 80% survived. The drug worked even if it was administered days after the infection began.
The drug worked alone and in combination with antivirals and it worked without compromising the body's ability to mount an immune response to the virus.
The study appeared in the journal Scientific Reports.
Source: IANS
Vaccines Developed For Chickens Against Two New Avian Influenza Strains
The vaccine contains a recombinant virus that fights against avian influenza virus subtype H5N1 that gets transmitted from poultry to humans.
Advertisement
The drug was effective against multiple strains of influenza, including the 2009 swine flu pandemic strain.
"While this research was conducted in mice, I found the results exciting since the drug was effective in two different strains of mice and three different strains of flu," said Warren Lee, a researcher with St. Michael's Hospital's Keenan Research Center for Biomedical Sciences, who tested the new drug on mice.
As the mechanism of blood vessels leaking into lungs is common throughout animals, Lee was optimistic that the drug could be effective in animals other than mice, including humans.
Without the drug, 100% of the mice died within one week. With the drug, more than 80% survived. The drug worked even if it was administered days after the infection began.
The drug worked alone and in combination with antivirals and it worked without compromising the body's ability to mount an immune response to the virus.
The study appeared in the journal Scientific Reports.
Source: IANS
Vaccines for Two Strains of Bird Flu Got Detailed in Kansas State University
Kansas State University researchers have detailed vaccine development for two new strains of avian influenza that can be transmitted from poultry to humans.
Advertisement
 Pediatric Swine Flu Patient Successfully Treated With Artificial Heart Lung MachineTreatment using the Extracorporeal Membrane Oxygenation machine costs around Rs.10-45 lakhs in India and cost over Rs.1 crore in foreign countries. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.
The recently created assay identifies antipsychotic drugs present in sweat.
